The Care of Stroke in Ziekenhuis Oost-Limburg

East Limburg Hospital

Status: Completed

Conditions: Stroke

Study type: Observational

Funder types: Other

Identifiers

NCT03355690

B371201733371/I/U

Details and patient eligibility

About

A stroke occurs when the blood circulation is hampered due an ischemic or hemorrhagic event. Previous, a stroke was treated only with anti-aggregation. Over time, multiple studies have showed a positive effect of intravenous thrombolysis with rt-PA (recombinant tissue plasminogen activator) in comparison with the standard treatment (anti-aggregation). Since 2015, thrombectomy was proven to have an added value in combination with thrombolysis. Thrombectomy is an endovascular technique where the thrombus is removed or fragmented.

Diagnosis and treatment of stroke will have a significant impact on the health-economic status of the patient. However, little data is known. Unfortunately, the outcome after diagnosis with a stroke is not well documented. Therefore, this follow-up study over a time period of one year, will give us a sufficient amount of data to evaluate patients diagnosed with a stroke in the hospital of Genk.

Enrollment: 564 patients

Sex: All

Ages: 18 to 110 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• signed informed consent
• older than 18 years
• diagnosed with stroke

Exclusion criteria

• younger than 18 years

Trial design

564 participants in 1 patient group

Stroke patients

Description:

Stroke patients are treated according to the clinical practice which can be divided into: anti-aggregation, thrombectomy and/or thrombolysis